Zhen Su, MD, MBA

Dr. Su has served as a member of our Board of Directors since August 2023.  Dr. Su has been the Chief Executive Officer of Marengo Therapeutics and member of its Board of Directors since July 2021. Prior to joining Marengo, Dr. Su served as Senior Vice President and Global Head of the Oncology Business Franchise for Merck KGaA from 2019 to 2021 and concurrently as US Head of the Oncology Business Unit from 2020 to 2021. Dr. Su was Chief Medical Officer of EMD Serono from  2017 to 2019. Dr. Su also held leadership roles with increasing responsibility at Sanofi Oncology and GSK. Before his industry career, Dr. Su served on the faculty of Duke University Medical School, where he led early Oncology clinical studies focusing on mRNA-based and cell-based immunotherapy and then the University of Florida, where he was the director of the Cell and Gene Therapy program. Dr. Su received his Doctor of Medicine from Technical University of Dresden in Germany and his MBA from the University of Toronto in Canada.